News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Jeanne Zucker, InfoMedics

Advertisement

Articles by Jeanne Zucker, InfoMedics

Professional Promotion Through Patient Understanding

ByJeanne Zucker, InfoMedics,Paul LeVine, InfoMedics
July 3rd 2007

Though it may sound paradoxical, the most effective deployment of a patient-feedback program is within a pharmaceutical brand's professional promotions

Advertisement

Latest Updated Articles

  • Professional Promotion Through Patient Understanding
    Professional Promotion Through Patient Understanding

    Published: July 3rd 2007 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

From Ambition to Advantage: How Life Sciences Leaders Are Scaling AI

2

Augmentin XR Becomes First Approval Under Commissioner’s National Priority Voucher Pilot Program

3

Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial

4

EU Opportunities: How EMA Support Programs Can Slash Drug Market Entry Costs by 90%

5

FDA Approves Waskyra For Treatment of Wiskott-Aldrich Syndrome

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us